AggreWell plates

By Press release
Tuesday, 27 January, 2009


Many protocols to differentiate human embryonic stem cells (hESCs) and induced pluripotent stem cells (hiPSCs) require the formation of embryoid bodies (EBs). Current methods for doing this are not reproducible and result in EBs that are heterogeneous in size and shape , leading to inefficient and uncontrolled differentiation. AggreWell plates contain microwells which can be used to aggregate hESCs and hiPSCs into uniform EBs. The AggreWell plate can be used to control the size of the EBs, allowing optimisation of differentiation protocols to specific lineages. The AggreWell plate standardises the production of EBs, reducing the variability associated with hESC and hiPSC differentiation.

StemCell Technologies

Email: cyndy.nauer@stemcell.com

Related Articles

Turning point — optimal antibiotics for golden staph bloodstream infections

Involving more than 150 hospitals across more than 14 countries, a global clinical trial supports...

Alloy implants that naturally dissolve after healing

Australian researchers have been developing biodegradable magnesium-based alloys that more...

Partnership eyes up gene-editing approaches to vision loss

A partnership will build on Australian ophthalmic research into mechanisms that damage nerve...


  • All content Copyright © 2026 Westwick-Farrow Pty Ltd